Baldrige Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$122K Buy
1,143
+12
+1% +$1.3K 0.05% 136
2022
Q4
$125K Sell
1,131
-68
-6% -$6.95K 0.06% 129
2022
Q3
$103K Hold
1,199
0.05% 131
2022
Q2
$109K Sell
1,199
-78
-6% -$6.92K 0.05% 131
2022
Q1
$105K Hold
1,277
0.04% 138
2021
Q4
$98K Sell
1,277
-49
-4% -$3.9K 0.04% 136
2021
Q3
$100K Sell
1,326
-48
-3% -$3.65K 0.04% 130
2021
Q2
$107K Buy
+1,374
New +$102K 0.05% 126

Other funds holding MRK

Baldrige Asset Management's MRK Position: Q1 2023 in Review

Baldrige Asset Management increased its Merck (MRK) stake by 1.1% in Q1 2023, buying an estimated $1.3K and bringing the position to 1,143 shares worth $122K. The position accounts for 0.05% of the portfolio, ranked #136.

Baldrige Asset Management first reported a position in MRK in Q2 2021 and has held it in 8 quarters since. The position peaked at $125K in Q4 2022. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • Baldrige Asset Management held 1,143 shares of Merck worth $122K as of Q1 2023.
  • Baldrige Asset Management bought 12 Merck shares in Q1 2023, an estimated $1.3K.
  • Merck made up 0.05% of Baldrige Asset Management's portfolio in Q1 2023, its #136 holding.
  • Baldrige Asset Management first reported a position in Merck in Q2 2021 and has held it in 8 quarters since.
  • Baldrige Asset Management's Merck position peaked at $125K in Q4 2022.
  • 3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on Baldrige Asset Management's 13F filing for Q1 2023, filed 17 Apr 2023.